Attached files

file filename
10-K - FORM 10-K - MERIDIAN BIOSCIENCE INCc08969e10vk.htm
EX-13 - EXHIBIT 13 - MERIDIAN BIOSCIENCE INCc08969exv13.htm
EX-23 - EXHIBIT 23 - MERIDIAN BIOSCIENCE INCc08969exv23.htm
EX-21 - EXHIBIT 21 - MERIDIAN BIOSCIENCE INCc08969exv21.htm
EX-31.1 - EXHIBIT 31.1 - MERIDIAN BIOSCIENCE INCc08969exv31w1.htm
EX-10.12 - EXHIBIT 10.12 - MERIDIAN BIOSCIENCE INCc08969exv10w12.htm
EX-10.18.2 - EXHIBIT 10.18.2 - MERIDIAN BIOSCIENCE INCc08969exv10w18w2.htm
EXCEL - IDEA: XBRL DOCUMENT - MERIDIAN BIOSCIENCE INCFinancial_Report.xls
EX-31.2 - EXHIBIT 31.2 - MERIDIAN BIOSCIENCE INCc08969exv31w2.htm
Exhibit 32
Certification of Chief Executive Officer and Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing with the Securities and Exchange Commission of the Annual Report of Meridian Bioscience, Inc. (the “Company”) on Form 10-K for the period ended September 30, 2010 (the “Report”), the undersigned officers of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:
  1.  
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
  2.  
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
     
/s/ John A. Kraeutler
 
John A. Kraeutler
   
Chief Executive Officer
   
November 29, 2010
   
 
   
/s/ Melissa A. Lueke
 
Melissa A. Lueke
   
Executive Vice President and
   
Chief Financial Officer
   
November 29, 2010